Zelboraf, Cotellic, Similar Melanoma Drugs May Cause Heart Problems: Study
A new study warns that some melanoma drugs used in combination may increase the risk of serious heart problems.
A new study warns that some melanoma drugs used in combination may increase the risk of serious heart problems.
Health Canada has added a pancreatitis warning to the melanoma drug Zelboraf following a safety review.
Roche’s melanoma skin cancer pill Zelboraf, actually appears to cause other, less deadly, forms of skin cancer to grow, some researchers report.